OpenVSafe by OpenVAERS
Search V-safe

2MM-29344-54915

3 vaccinations 1 coded response 14 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
481 / MI
Registered
2021-11-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-07
    Dose 2 — Pfizer-BioNTech
  3. 2021-11-05
    Dose 3 — Moderna
  4. 2021-11-06
    Registered in v-safe
  5. 2021-11-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-11-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-11-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2021-11-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-11-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2021-11-12
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2021-11-19
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  12. 2021-11-26
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-12-03
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  14. 2021-12-10
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  15. 2021-12-17
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-02-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-05-06
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-11-05
    Survey response — 12 months, dose 3
    MedDRA: Respiratory syncytial virus infection, Sinusitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Had RSV and sinus infection. Clear now!
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-11-05
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  20. 2022-11-07
  21. 2022-11-08
  22. 2022-11-08

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech No
22021-05-07Pfizer-BioNTech No
32021-11-05Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-11-05 Unsuccessful

Free text

Release 12 — 12 months, dose 3

2022-11-05

Symptoms: Had RSV and sinus infection. Clear now!

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRespiratory syncytial virus infection · · ✓
SDSinusitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release